Companies cannot wait for the picture to become clear. They need to start now: assessing how Brexit might affect their business and future strategy; defining what risks might emerge; and outlining how best to address these challenges. How do you assess Brexit’s impact on immigration considerations?
So, 52 percent of the British have voted to leave the EU yesterday, sending shockwaves around the world. What now? This article provides a snapshot of what could be the future from an indirect tax perspective.
Life science companies have to future-proof their value chain by placing functions, assets and risks in locations where they are planning to have their profits taxed. Structures where profit allocations are made in tax-beneficent locations with little or no substance are no longer viable.